Teladoc Health (TDOC) Depreciation & Amortization (CF) (2014 - 2023)

Teladoc Health has reported Depreciation & Amortization (CF) for 10 years, with the latest figure at $94.3 million in Q3 2023.

• Quarterly Depreciation & Amortization (CF) rose 52.08% year-over-year to $94.3 million in Q3 2023, while the trailing twelve-month figure through Jun 2024 was $94.3 million (down 66.67% YoY) and the FY2022 annual result came in at $256.0 million, up 25.36% from the prior year.
• Depreciation & Amortization (CF) improved to $94.3 million in Q3 2023 per TDOC's latest filing, from $75.5 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $94.3 million in Q3 2023 and troughed at $5.1 million in Q4 2019.
• A 5-year average of $42.5 million and a median of $51.3 million in 2021 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2019 and 2020: Depreciation & Amortization (CF) slumped 46.72% in 2019, then surged 625.84% in 2020.
• Over 5 years, Depreciation & Amortization (CF) stood at $5.1 million in 2019, then soared by 625.84% to $37.0 million in 2020, then surged by 41.59% to $52.3 million in 2021, then surged by 44.68% to $75.7 million in 2022, then advanced by 24.55% to $94.3 million in 2023.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $94.3 million, $75.5 million, and $69.8 million for Q3 2023, Q2 2023, and Q1 2023 respectively.